Your browser doesn't support javascript.
loading
[LIFESTYLE ADJUSTMENT AS THERAPEUTIC TOOL IN THYROID EYE DISEASE].
Vashdi, Inon; Gur, Zvi.
Afiliación
  • Vashdi I; Faculty of Medicine, The Hebrew University of Jerusalem.
  • Gur Z; Ophthalmology Division, Hadassah Ein Kerem, The Hebrew University of Jerusalem.
Harefuah ; 161(4): 223-227, 2022 Apr.
Article en He | MEDLINE | ID: mdl-35466606
ABSTRACT

OBJECTIVES:

Thyroid Eye Disease (TED), also known as Graves' ophthalmopathy, is the most frequent extrathyroidal manifestation of autoimmune dysthyroidism. The most common ocular signs are eyelid retraction, proptosis, and strabismus, alongside specific dermatopathies. This article aims to review the options to improve TED manifestation by lifestyle adjustment.

RESULTS:

Tobacco smoking is the strongest risk factor for the development of TED and is associated with increased incidence and severity of TED and reduction in response to treatment. Smoking cessation decreases the incidence of TED and compares the risk level of ex-smokers to the risk level of the general population. Selenium is a chemical element with anti-oxidative properties. Selenium levels were significantly lower in Graves' disease patients with TED compared with those without TED. A double-blinded, randomized-control trial demonstrated that supplementation of selenium was associated with improved quality of life, decreased ocular involvement, and slowed TED progression while taken for a limited period. Statins administration to thyroid patients is associated with a reduced risk of TED. Recently, a few studies have shown an increased risk of developing TED and increased severity depending on the level of lipids in the blood, which suggests that balancing blood lipid levels by statins or by low-fat diet can help prevent TED.

CONCLUSIONS:

Lifestyle adjustment might be critical for a significant portion of patients. By supporting smoking cessation, the recommendation of selenium supplementation for a limited period and reducing serum cholesterol levels can prevent the development of TED, reduce its severity, and improve the patient's quality of life.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Selenio / Enfermedad de Graves / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Oftalmopatía de Graves Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Risk_factors_studies Aspecto: Patient_preference Límite: Humans Idioma: He Revista: Harefuah Año: 2022 Tipo del documento: Article
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Selenio / Enfermedad de Graves / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Oftalmopatía de Graves Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Risk_factors_studies Aspecto: Patient_preference Límite: Humans Idioma: He Revista: Harefuah Año: 2022 Tipo del documento: Article